We are live on ! Find out more
INFU icon

InfuSystem Holdings

86 hedge funds and large institutions have $119M invested in InfuSystem Holdings in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

48% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 21

29% more capital invested

Capital invested by funds: $92.7M → $119M (+$26.7M)

10% more funds holding

Funds holding: 7886 (+8)

1.58% more ownership

Funds ownership: 64.88%66.46% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

77% less call options, than puts

Call options by funds: $68K | Put options by funds: $291K

Holders
86
Holders Change
+8
Holders Change %
+10.26%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
31
Reduced
21
Closed
6
Calls
$68K
Puts
$291K
Net Calls
-$223K
Net Calls Change
-$232K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$765K +$75.6K +9,597 +12%
N
27
Nuveen
North Carolina
$730K +$83.9K +10,647 +14%
PAM
28
Panagora Asset Management
Massachusetts
$723K +$158K +19,999 +30%
Millennium Management
29
Millennium Management
New York
$646K +$35.7K +4,532 +6%
KPP
30
Kings Path Partners
Texas
$640K
Citadel Advisors
31
Citadel Advisors
Florida
$531K -$156K -19,804 -24%
UBS Group
32
UBS Group
Switzerland
$525K +$411K +52,117 +522%
JP Morgan Chase
33
JP Morgan Chase
New York
$504K +$348K +44,106 +284%
Charles Schwab
34
Charles Schwab
California
$485K
BA
35
Bard Associates
Illinois
$478K
GCP
36
GSA Capital Partners
United Kingdom
$463K -$85.6K -10,867 -17%
Marshall Wace
37
Marshall Wace
United Kingdom
$451K +$252K +32,015 +150%
PCM
38
Perritt Capital Management
Illinois
$372K +$43.3K +5,500 +14%
Two Sigma Investments
39
Two Sigma Investments
New York
$306K +$82.2K +10,427 +40%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$278K +$156K +19,813 +152%
Barclays
41
Barclays
United Kingdom
$266K +$22.7K +2,882 +10%
OAM
42
Oppenheimer Asset Management
New York
$235K -$44K -5,584 -17%
Deutsche Bank
43
Deutsche Bank
Germany
$234K +$130K +16,526 +148%
Connor, Clark & Lunn Investment Management (CC&L)
44
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$204K +$88.3K +11,203 +86%
Bank of America
45
Bank of America
North Carolina
$200K +$79.4K +10,074 +74%
AIP
46
ARS Investment Partners
New York
$184K -$14.6K -1,853 -8%
WG
47
Winton Group
United Kingdom
$164K +$153K +19,410 New
HighTower Advisors
48
HighTower Advisors
Illinois
$156K
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$132K -$9.17K -1,163 -7%
CC
50
Corton Capital
Ontario, Canada
$130K +$121K +15,373 New

INFU Hedge Fund Activity: Q4 2024 in Review

86 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in InfuSystem Holdings (INFU) for Q4 2024, worth a combined $119M — up 29% from $92.7M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new INFU positions and 6 closed out — a net gain of 8 holders — while 31 added to existing stakes and 21 trimmed.

The largest buyer was First Eagle Investment Management, adding an estimated $1.47M. The largest seller was Royal Bank of Canada, cutting an estimated $629K.

  • 86 institutional investors held InfuSystem Holdings (INFU) as of Q4 2024, up from 78 in Q3 2024.
  • Funds reported $119M of InfuSystem Holdings stock for Q4 2024, up 29% quarter-over-quarter.
  • 14 funds opened new InfuSystem Holdings positions in Q4 2024 and 6 closed out, a net change of +8 holders.
  • The largest InfuSystem Holdings buyer in Q4 2024 was First Eagle Investment Management, an estimated $1.47M added.
  • The largest InfuSystem Holdings seller in Q4 2024 was Royal Bank of Canada, an estimated $629K sold.

Based on aggregated 13F filings for Q4 2024.